Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles

被引:43
|
作者
Rao, N. Hanumantha [1 ]
Babu, P. Baji [1 ]
Rajendra, L. [1 ]
Sriraman, R. [1 ]
Pang, Yuk-Ying S. [2 ]
Schiller, John T. [2 ]
Srinivasan, V. A. [1 ]
机构
[1] Indian Immunol Ltd, Ctr Res & Dev, Hyderabad 500032, Andhra Pradesh, India
[2] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA
关键词
Cervical cancer; Prophylactic vaccine; Virus like particles; Yeast; Pseudovirus neutralization assay; CERVICAL-CANCER; HPV VACCINATION; VACCINES; DISEASES; PROMISE;
D O I
10.1016/j.vaccine.2011.07.071
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major capsid protein (L1) of human papillomaviruses (HPV) expressed in heterologous systems assembles into virus-like particles (VLPs). We report cloning and expression of codon optimized HPV L1 genes of the two high-risk HPV types 16 and 18 in methylotropic yeast. Pichia pastoris. The VLPs produced in P. pastoris were subjected to three step purification method involving density gradient centrifugations and size exclusion chromatography. The enriched VLPs were characterized using conformation-specific monoclonal antibodies in ELISA and by transmission electron microscopy. Mice immunized with a bivalent HPV16 and HPV18 VLPs developed high serum antibody titers to both HPV types that persisted for 190 days post vaccination. Serum of mice immunized with the HPV-VLP preparations could neutralize homologous pseudoviruses in an in vitro assays. Our results demonstrate that the L1 proteins expressed in P. pastoris fold properly as evidenced by assembly into VLPs and induction of type-specific neutralizing antibody response in mice. This work constitutes a step towards developing an alternate production platform for generating an affordable HPV vaccine to meet the needs of developing countries. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7326 / 7334
页数:9
相关论文
共 50 条
  • [41] ORGANIZATION OF THE MAJOR AND MINOR CAPSID PROTEINS IN HUMAN PAPILLOMAVIRUS TYPE-33 VIRUS-LIKE PARTICLES
    SAPP, M
    VOLPERS, C
    MULLER, M
    STREECK, RE
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 2407 - 2412
  • [42] Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles
    Shebl, Fatma M.
    Pinto, Ligia A.
    Garcia-Pineres, Alfonso
    Lempicki, Richard
    Williams, Marcus
    Harro, Clayton
    Hildesheim, Allan
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (04) : 978 - 981
  • [43] DETECTION OF PROTEIN AGGREGATES, BUT NOT VIRUS-LIKE PARTICLES, WHEN THE MAJOR (L1) COAT PROTEIN OF A WILD-TYPE HUMAN PAPILLOMAVIRUS TYPE-16 (HPV-16) IS EXPRESSED IN INSECT CELLS
    CASON, J
    KAMBO, PK
    JEWERS, RJ
    BEST, JM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (03) : S335 - S335
  • [44] EFFICIENT SELF-ASSEMBLY OF HUMAN PAPILLOMAVIRUS TYPE-16 L1 AND L1-L2 INTO VIRUS-LIKE PARTICLES
    KIRNBAUER, R
    TAUB, J
    GREENSTONE, H
    RODEN, R
    DURST, M
    GISSMANN, L
    LOWY, DR
    SCHILLER, JT
    JOURNAL OF VIROLOGY, 1993, 67 (12) : 6929 - 6936
  • [45] Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae
    Hofmann, KJ
    Neeper, MP
    Markus, HZ
    Brown, DR
    Muller, M
    Jansen, KU
    JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 465 - 468
  • [46] Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
    Brown, DR
    Fife, KH
    Wheeler, CM
    Koutsky, LA
    Lupinacci, LM
    Railkar, R
    Suhr, G
    Barr, E
    Dicello, A
    Li, WL
    Smith, JF
    Tadesse, A
    Jansen, KU
    VACCINE, 2004, 22 (21-22) : 2936 - 2942
  • [47] Mapping the B cell epitopes within the major capsid protein L1 of human papillomavirus type 16
    Wang, Aiping
    Li, Ning
    Zhou, Jingming
    Chen, Yumei
    Jiang, Min
    Qi, Yanhua
    Liu, Hongliang
    Liu, Yankai
    Liu, Dongmin
    Zhao, Jianguo
    Wang, Yanwei
    Zhang, Gaiping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 118 : 1354 - 1361
  • [48] Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer
    Heim, K
    Widschwendter, A
    Pirschner, G
    Wieland, U
    Awerkiew, S
    Christensen, ND
    Bergant, A
    Marth, C
    Höpfl, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) : 705 - 711
  • [49] Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles
    Fraillery, Dominique
    Zosso, Nathalie
    Nardelli-Haefliger, Denise
    VACCINE, 2009, 27 (17) : 2326 - 2334
  • [50] Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris
    Gupta, Jyoti
    Kaul, Sheetal
    Srivastava, Akriti
    Kaushik, Neha
    Ghosh, Sukanya
    Sharma, Chandresh
    Batra, Gaurav
    Banerjee, Manidipa
    Shalimar
    Nayak, Baibaswata
    Ranjith-Kumar, C. T.
    Surjit, Milan
    FRONTIERS IN MICROBIOLOGY, 2020, 11